Groupe de RFA RADIO

Research into gene-based therapies offers hope for future treatment advances. While still experimental, these approaches aim to address the root cause of the disorder.

Improved drug delivery systems and personalized dosing strategies may further enhance disease management.

Ongoing innovation signals a promising future for individuals affected by X-linked AHC.